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Abstract Oral keratinocytes of buccal and gingival tissues
undergo a terminal differentiation program to form a protective
epithelial barrier as non-keratinized or parakeratinized stratified
cells. We have examined the protein composition of cell envelopes
(CEs) from normal human buccal and gingival tissues as well
as keratinocytes from normal human gingival cells grown in
culture. Biochemical and sequencing analyses reveal that the CEs
contain 60^70% small proline-rich protein 1a/b (SPR1a/b),
together with smaller amounts of involucrin, annexin I and
several other known CE proteins. The data imply a specialized
role for SPR1 proteins in the unique barrier function require-
ments of oral epithelia. ß 2000 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
A primary function of strati¢ed squamous epithelia is to
provide a physical and chemical barrier against the environ-
ment. This is a¡orded by a specialized structure termed the
cell envelope (CE), which is an insoluble protein layer formed
beneath the plasma membrane [1^3]. The CE is formed during
terminal di¡erentiation by a well-de¢ned program of events
involving the sequential deposition of envelope precursor pro-
teins. These proteins are crosslinked into an insoluble amal-
gam by disul¢de bonds and by NO-(Q-glutamyl)lysine and/or
bis-(Q-glutamyl)-spermidine isopeptide bonds formed by the
action of transglutaminases (TGases). TGases are a family
of Ca2-dependent enzymes that catalyze the crosslinking of
proteins through the formation of isopeptide bonds between
protein-bound glutamines and amines such as polyamines or
the O-NH2 of protein-bound lysine residues [1^3,5,6]. Kerati-
nocytes are known to contain at least three major isoforms,
TGases 1, 2 and 3. TGase 1 exists largely as a membrane-
bound form and is induced during epidermal di¡erentiation in
skin and other squamous epithelia where it plays a key role in
the formation of CEs. TGase 3 is primarily cytosolic and is
expressed in certain orthokeratinizing epithelia where it too is
important for CE assembly. TGase 2, also termed tissue
TGase, is a cytosolic enzyme found in most cells and tissues.
While it has been implicated in several cellular processes in-
cluding apoptotic body formation, cell adhesion, metastasis,
extracellular matrix stabilization and G-protein-mediated sig-
nal transduction, its role in the terminal di¡erentiation of
program of keratinocytes remains unclear.
Many proteins, including annexin I, cystatin K, desmopla-
kin, ela¢n, envoplakin, ¢laggrin, involucrin, type II keratin
intermediate ¢lament chains, loricrin, periplakin and the small
proline-rich proteins (SPRs) are now known by protein se-
quencing analyses to be components of CEs and are cross-
linked by TGases 1 and/or 3 [3,7,8]. Recent data suggest that
CEs from various squamous epithelia may be built from a
common sca¡old consisting of envoplakin, involucrin, desmo-
plakin and SPRs, but the proteins deposited for reinforcement
appear to vary widely depending on the epithelium [9]. For
example, loricrin is the major component of the so-called rigid
CEs derived from normal epidermal tissues, accounting
for 80% of the total CE protein, but it is much less ex-
pressed in fragile envelopes prepared from psoriatic epidermis
or cultured skin keratinocytes, or many other internal
epithelia. Similarly, SPRs vary widely in amount in epithelia,
from 6 1% in interfollicular epidermis, 5% in foreskin epider-
mis, about 10% in lip, palm and sole/footpad epidermis,
to s 20% in rodent forestomach epithelium [9,10]. Thus the
di¡erent specialized barrier functional requirements of various
epithelia may be re£ected by the protein composition of their
CEs, and especially the SPRs.
SPRs consist of three families of about 10 related proteins:
SPR1 (two members SPR1a and SPR1b), SPR2 (7^8 ex-
pressed members) and one SPR3 protein [3,4]. All SPRs con-
tain head and tail domains enriched in glutamines and lysines
which are involved in crosslinking. Their central domains con-
sist of varying numbers of proline-rich peptide repeats. Indi-
vidual SPRs are di¡erentially expressed in strati¢ed squamous
epithelia and most epithelial cell types express only a subset of
SPRs. For example, in the human upper digestive tract, SPR1
proteins are expressed in sublingual, tongue, gingival and buc-
cal epithelia, SPR2 in lingual papillae and SPR3 in esophageal
epithelium [11^15]. Together, such di¡erential expression of
SPRs suggests that the SPR multigene family evolved to serve
specialized roles in barrier function [9,10]. SPR proteins be-
come crosslinked to themselves as well as many protein part-
ners and thereby seem to function as crossbridging proteins in
CEs [9,10].
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Extensive biochemical characterization of epithelial di¡er-
entiation has been carried out using human and mouse epi-
dermal tissue. Epidermal keratinocytes in culture can be in-
duced to undergo terminal di¡erentiation by high Ca2
concentration and to express marker proteins as well as CE
precursors such as keratins 1 and 10, involucrin, ¢laggrin,
SPRs and TGase 1 [16]. In contrast, there is only limited
information on the di¡erentiation programs of oral epithelia
and in particular the molecular composition of their CEs.
Expression of TGase 1, involucrin and SPRs have been re-
ported in human oral and tracheal epithelia [11^15,17], and a
terminal di¡erentiation program and CE formation similar to
those in epidermis are presumed to occur. Oral epithelia are
constantly exposed to salivary proteins, growth factors, pro-
teases, other bioactive molecules in saliva, as well as various
microorganisms and substances released by these organisms
that may have toxic e¡ects on the tissue. Thus, it bears an
important and specialized barrier function against physical,
mechanical, chemical and biological insults. In this report,
we present evidence that the major protein component of
human buccal and gingival keratinocyte CEs are SPR1a/b
proteins.
2. Materials and methods
2.1. Cell culture
Normal human gingival keratinocyte (NHGK) cells were isolated
from small pieces of gingival tissue excised from a healthy volunteer
during retromolar extraction at the Clinical Research Core of the
National Institute of Dental and Craniofacial Research. The excised
tissue was washed in Hanks balanced salt solution and treated with
dispase (2.4 U/ml, Boehringer Mannheim) at 37‡C for 30 min. The
epithelial sheet was separated from the underlying dermal tissue and
digested with a 0.05% trypsin solution containing 0.02% EDTA (tryp-
sin^versene mixture, Biowhittaker, Walkersville, MD, USA) at 37‡C
for 30 min. The detached epithelial cells were cultured in keratinocyte
growth medium (KGM) (Clonetics, San Diego, CA, USA) containing
0.15 mM Ca2 in a 60 mm tissue culture dish. After 1^2 weeks, when
cultures were near con£uence, the cells were subcultured into 10^20
dishes (60 mm). This secondary culture was used for experiments.
2.2. Preparation of CEs
When NHGK cells reached con£uence, terminal di¡erentiation was
induced by switching the medium to KGM containing 1.2 mM Ca2.
After 5 days, cells were harvested by centrifugation. Cell scrapings
using a dental brush were collected from the buccal mucosa of normal
human subjects, and cells were pelleted by centrifugation. Buccal or
cultured cell pellets and gingival epithelial fragments were resuspended
and boiled in a bu¡er of 0.1 M Tris^HCl (pH 9.0) containing 2% SDS
and 1% DTT for 15 min, and centrifuged at 5000Ug for 10 min to
remove soluble proteins in the supernatant [18]. The pellets were re-
suspended in the same solution and the boiling and centrifugation
cycle was repeated 5^6 times with intermittent sonication of the pellets
for the complete extraction of soluble proteins.
2.3. Protein chemistry procedures
Amino acid compositions were determined following acid hydroly-
sis for 22 h in 5.7 N HCl in vacuo. Compositions were modeled for
protein amounts as before [19,20] using the amino acids Asx, Ser, Glx,
Pro, Gly, Ala, Val, Cys, Leu and Lys. Suspensions of CEs (1 mg/ml)
were digested with 1:100 (w/w) trypsin (Sigma, sequencing grade) in
0.1 M NH4HCO3, pH 8.3, for 17 h at 37‡C. The insoluble pellet was
subjected to a second round of digestion with 1:100 (w/w) proteinase
K (Sigma, sequencing grade) in the same bu¡er for 17 h at 37‡C.
Soluble peptides were separated by reverse phase high performance
liquid chromatography (HPLC) on a 4.6U150 mm C18 column (Phe-
nomenex) with a gradient of acetonitrile as described [9,20]. Selected
peptides were covalently attached to Sequalon-AA membranes (Milli-
pore) and sequenced on a Porton LF 3000 gas phase protein se-
quencer (Beckman Instruments) [21,22].
2.4. TGase analyses
NHGK cells (8U105) were resuspended and sonicated in 1 ml of
0.1 M Tris^acetate bu¡er, pH 7.5, containing 1 mM EDTA, and the
protease inhibitors (5 Wg/ml leupeptin, 5 Wg/ml aprotinin, 50 Wg/ml
calpain inhibitor I, 100 Wg/ml bestatin and 1 mM PMSF). TGase
enzymes were assayed from the supernatant (cytosol) or membrane
fraction following release with 0.1% Triton X-100 [23^26]. TGase
activity assays were performed by measurement of the incorporation
of [1,4-14C]putrescine into succinylated casein [21]. Immuno-slot blot-
ting of the cytosolic and membrane-bound fractions of NHGK cells
were done using a standard procedure [24,25] followed by reaction
with speci¢c TGase 1 and 2 antibodies, and detected using enhanced
chemiluminescence (Pierce, Rockford, IL, USA).
2.5. Reverse transcription-polymerase chain reaction (RT-PCR)
analyses
Total RNA was isolated from NHGK cells using the TRIZOL
reagent (Gibco BRL, MD, USA). The reverse transcription reaction
was carried out at 42‡C using AMV reverse transcriptase (Clontech,
CA, USA). One Wl of this reaction mixture was used as template in all
PCR reactions. The oligonucleotide primer pairs used were: TGase 1
(361 bp) sense: GAT TGT CTT CAA GAA CCC CCT TCC C;
antisense: TCA TCT GAC TCC AGT CCC ATT GCT C; TGase
2 (310 bp) sense: CTC GTG GAG CCA GTT ATC AAC AGC
TAC; antisense: TCT CGA AGT TCA CCA CCA GCT TGT G;
L-actin (838 bp) sense: ATC TGG CAC ACC TTC TAC AAT GAG
CTG CG; antisense: CGT CAT ACT CCT GCT TGC TGA TCC
ACA TCT GC; SPR1a/b (385 bp) sense: CAC ACC AGG ACC
AGC CAC TGT TGC AGC; antisense: TGC AAG GCA AAT
GGG ACT CAT ACA CAG; annexin I (474 bp) sense: ATG GCA
ATG GTA TCA GAA TTC CTC AAG; antisense: TTA CTC TCT
GTA GAC CCT GTT AAT GTC, and involucrin (339 bp) sense:
AAG GGA GAA GTA TTG CTT CCT GTA GAG; antisense:
TGG GGA AGT AAG GAT TCC TAT AGT AAC. Primers were
designed for speci¢c regions and constructed to span an intron in
order to distinguish cDNA from DNA transcribed from a genomic
DNA template. The conditions for PCR were as described elsewhere
[24^26]. PCR products were separated on 6% TBE gel (Novex, CA,
USA) and radioactive bands detected using a phosphoimager (Molec-
ular Dynamics Co., MN, USA). The PCR products corresponded to
the expected sizes of cDNA (see Fig. 1D, inset).
3. Results
3.1. Ca2+-dependent formation of CEs in NHGK cells
In Fig. 1, we document a series of experiments to demon-
strate that NHGK cells, like epidermal keratinocytes, can be
induced to assemble a CE structure in a Ca2-dependent man-
ner in vitro in con£uent cultures containing 1.2 mM Ca2
concentration. First, as de¢ned by use of a light-scattering
assay, the NHGK cells formed CEs within 3^5 days (Fig.
1A). This increased CE formation correlated precisely with
marked increases in TGase activity in the membrane fraction
of the NHGK cells, whereas cytosolic activity changed little
(Fig. 1B). This activity increase was due to the membrane-
bound TGase 1 isoform (Fig. 1C) rather than the cytosolic
TGase 2 or 3 (not expressed) isoforms. Furthermore, measure-
ment of the amounts of mRNAs by RT-PCR of three impor-
tant CE precursor proteins and the TGase 1 and 2 enzymes
revealed coincident modest increases for SPR1 and involucrin,
major increases for annexin I and TGase 1, but a marked
decrease for TGase 2 mRNAs. Together, these data indicate
that NHGK cells can be induced to undergo a terminal di¡er-
entiation program that involves production of a CE barrier
structure.
3.2. CEs from gingival and buccal tissues and cultured NHGK
cells are biochemically very similar
First, we performed amino acid analyses on CEs isolated
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from intact gingival and buccal mucosal tissues, as well as
NHGK cells cultured to con£uency for 5 days. Using estab-
lished modeling algorithms [19,20], we then estimated the
amounts of several major protein species likely to be present
(Table 1). The CE preparations were generally very similar
and notably enriched in Pro residues, from which we can
predict that they contain similarly high levels (60^65%) of
SPRs together with smaller amounts of involucrin, desmopla-
kin/envoplakin, annexin I and loricrin. Their crosslink con-
tents were 1.3^1.5 residues/100. Together, these data suggest
that the CEs formed in terminally di¡erentiating cultured
NHGK cells are biochemically similar to those of intact buc-
cal or gingival tissues. While the amount of crosslink is com-
parable to levels seen in epidermal [22] or forestomach [9]
CEs, the estimated extraordinarily high content of SPRs in
these oral epithelial CEs is unique.
3.3. Protein sequencing analyses of peptides recovered from
CEs of NHGK cells
Protein sequencing analyses were performed in order to
characterize the nature and extent of proteins crosslinked in
the NHGK CEs. We recovered 210 Wg of CEs from cells
cultured for 5 days in high Ca2 medium. These were ¢rst
digested with trypsin, and the tryptic-soluble products
(110 Wg) were resolved by HPLC (Fig. 2A). Trypsin-insoluble
material (100 Wg) was digested further with proteinase K, after
which 70 Wg remained insoluble and the solubilized 30 Wg were
used for fractionation by HPLC (Fig. 2B). Aliquots of each
protease fraction were used for crosslink quantitation, and
amino acid analysis followed by modeling of protein amounts
(Table 1).
The soluble tryptic peptides (Fig. 2A) were dominated by
two overlapping peaks eluted at 31^33 min of sequence
VPEPCQPK and VPEPCHPK, respectively, and which corre-
spond exactly to the two repeat motifs characteristic of the
central domain of human SPR1a/b proteins. Assuming that
none of these sequences was involved in crosslinking, as found
before [10], and based on the numbers of these repeats in
human SPR1a/b proteins [27], the yields of the two peptides
indicate that the original 210 Wg of NHGK CEs contained at
least 60% SPR1a/b proteins. In addition, a broad poorly-re-
solved peak eluted near the end of the chromatogram. This is
reminiscent of in vitro experiments with SPR proteins [28,29],
and is suggestive of the presence of densely crosslinked mate-
rial. While, it could not be further analyzed by protein se-
quencing, its amino acid composition was similar to that ex-
pected for SPR1 head and tail domains, and aliquots across
the peak were enriched in Pro- and Gln-rich sequences (data
not shown). Also, it contained about 2.8 mol/mol of crosslink
(Table 1), which corresponds to about 5.2 mol of crosslink per
head+tail domain of SPR1 proteins. This is the highest den-
sity of head/tail domain crosslinking of SPRs reported so far,
although this broad peak is likely to contain crosslinked se-
quences of other CE proteins as well.
However, the soluble proteinase K peptides recovered from
the trypsin pellet yielded a number of well-resolved peptide
peaks, in addition to another broad unresolved peak late in
the chromatogram (Fig. 2B). Table 2 lists the sequences ob-
tained, as well as an estimate of their molar recoveries. In no
case did we ¢nd two or more sequences adjoined by a cross-
link, which means the listed peptides originated from uncross-
linked parts of CE proteins that nevertheless had been linked
Fig. 1. CE formation in NHGK cells. A: Pre-con£uent (PC)
NHGK cell or post-con£uent cells cultured in media containing
0.05, 0.15 and 1.2 mM Ca2 for 1, 3 and 5 days were used for the
detection of CE formation by light-scattering. CEs from 1U107 cells
were resuspended in 1 ml of bu¡er and turbidity measured at
310 nm. B: TGase activity in the cytosolic and membrane fractions
were measured in pre- or post-con£uent NHGK cells incubated as
above. C: The membrane and cytosolic fractions were used for im-
muno-slot blotting with speci¢c antibodies for TGase 1 and TGase
2 for pre- or post-con£uent (5 days after con£uence in 0.15 mM
Ca2) cultures of NHGK cells. D: Total RNA was isolated from
NHGK cells pre-con£uent (PC) or after 5 days of con£uence in me-
dia containing 0.05, 0.15 or 1.2 mM Ca2 and used for RT-PCR
analyses of expression of SPR1, annexin I, involucrin, TGase 1 and
TGase 2 mRNAs.
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together through residues elsewhere in their sequences. The
most abundant protein species was involucrin (13% of total),
followed by annexin I (7%), loricrin, envoplakin and SPR1
(4% each), desmoplakin and cystatin K (9 2% each).
Table 1
Amino acid compositions (residues/100 residues) and modeled amounts of proteins of CEs
Amino acida Gingival tissue Buccal tissue NHGK cells
cells trypsin proteinase K
Sb P S P
Asp+Asn 4.1 4.0 5.4 6.5 4.3 4.3 4.1
Thr 3.6 3.4 3.8 3.7 3.2 3.6 2.8
Ser 3.2 3.3 3.5 5.4 4.1 5.2 5.3
Glu+Gln 17.2 17.0 17.5 16.9 17.0 17.2 16.4
Pro 20.8 19.3 19.9 15.0 20.2 19.4 21.1
Gly 6.7 6.6 5.6 6.4 6.4 4.7 8.2
Ala 5.1 5.0 5.2 3.9 5.6 4.9 5.7
Cys 5.8 7.4 4.6 7.9 8.2 7.9 8.2
Val 5.4 5.2 5.1 6.7 4.0 4.9 3.2
Met 0.9 0.8 1.5 1.7 0.6 0.7 0.4
Ile 3.3 3.1 2.3 2.3 2.3 2.5 1.4
Leu 7.7 7.5 6.5 5.7 6.7 5.5 6.8
Tyr 1.0 1.0 2.2 1.0 2.3 1.2 2.4
Phe 0.7 0.8 2.0 1.1 2.1 2.7 1.5
His 3.7 3.6 3.3 4.5 2.5 3.3 1.2
Lys 9.0 8.7 8.4 7.9 8.6 7.5 8.6
Arg 1.9 2.1 3.2 1.7 3.6 4.4 2.8
Crosslink 1.5 1.4 1.3 1.0 1.5 0.0 4.8
Protein Modeled amountsa (%)
SPRs 70 70 65 50 W70e W60 W70e
Loricrin 5 10 6 5 5 10
Annexin I 5 5 10 10 6 5 W10 6 5
Involucrin 10 10 10 10 6 5 W10 6 5
Plakinsc 5 5 5 10 6 5 W10 6 5
GenBankd 6 5 6 5 10 20 s 20e W10 s 20e
aNumbers may not add up to 100 due to rounding.
bS, supernatant; P, undigested pellet.
cPlakins means average composition of envoplakin and desmoplakin.
dThis is included to rationalize the modeled amounts: in this study, a high content probably suggests a poor ¢t due to loss by proteolysis of
some sequences of proteins.
eThese numbers are unreliable, probably due to loss of some sequences of proteins.
Fig. 2. HPLC pro¢les of trypsin (A) and proteinase K (B) soluble
peptides.
Table 2
Amino acid sequences of peptides from Fig. 2B
Peak Sequencea Protein Estimated
% amountb
1 86-QETGK annexin I 1
2 504-EQQEK involucrin 4
3 22-VQTVK annexin I 1
4 303-HQTQQK loricrin 1
5 581-PPKHK involucrin 1
6 301-VTGPGG desmoplakin 2
7 25-QLEEK cystatin K 2
8 131-GTDEDTL annexin I 1
9 1971-QDESSY envoplakin 4
10 53-SGGGGYc loricrin 3
11 93-EQHEEY involucrin 4
12 560-PTKGEVL involucrin 4
13 ?-VPEP[E/Q][E/Q][E/Q]d SPR1 4
14 69-PEPCPSI SPR1 4
15 317-GISLC annexin I 4
aSequence of only the ¢rst 5^7 Edman degradation cycles is shown;
numbers refer to location in protein as reported in databases.
bBased on total initial amount of NHGK CE protein.
cAlso present in keratin 1, which is not expressed in NHGK cells
(data not shown).
dSequence uncertainty due to mixed sequences or partial deamida-
tion of glutamines.
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Finally, the proteinase K pellet (33% of total CE protein
mass) retained extraordinarily high contents of crosslink (4.8
residues/100 residues), as well as Pro and Glx residues. How-
ever, mathematical modeling yielded ambiguous results, pre-
sumably due to the fact that after two cycles of proteolysis,
many proteins had been severely pruned and could thus no
longer be used for meaningful predictions. The data never-
theless suggest extensively crosslinked SPR protein head/tail
remnants, as well as other minor protein constituents. In ad-
dition, the higher contents of Gly and Cys were suggestive of
the presence of loricrin.
4. Discussion
The present experiments were initially designed to assess
whether oral keratinocytes undergo a program of terminal
di¡erentiation and form a CE barrier structure as do other
types of strati¢ed squamous epithelia. The expression charac-
teristics in NHGK of three ubiquitous CE precursor proteins
as well as the TGase 1 enzyme are consistent with the forma-
tion of large amounts of CEs following 5 days of culture in
high Ca2 medium, are somewhat similar to other epithelia
such as epidermal keratinocytes, and are consistent with nu-
merous earlier studies [11^15]. Modeling analyses of the com-
positions of CEs recovered from gingival and buccal tissues
and cultured NHGK cells revealed near identities in biochem-
ical properties. Furthermore, the amounts of various CE pre-
cursor proteins found following amino acid sequencing were
similar to those estimated to be present in the intact tissues
and NHGK cells by modeling (cf. Tables 1 and 2). The con-
tents of desmoplakin, envoplakin and involucrin were similar
to those of other cultured keratinocytes [8,22], suggesting that
CE assembly in NHGK cells is initiated by a pathway which
is common to many other types of strati¢ed squamous epi-
thelia [8]. However, NHGK CEs di¡ered from those of epi-
dermal keratinocytes by much lower contents of loricrin and
the TGase 3 enzyme, somewhat higher contents of annexin I
and the TGase 1 enzyme, and notably by the extraordinarily
high contents of SPR1a/b proteins. Indeed, our modeling and
sequencing analyses reveal that NHGK CEs contain by far
the highest content of SPR proteins reported in any epithelial
cell type. This is unlikely to be due to an artifact of culturing,
since buccal and gingival tissue CEs were estimated to contain
similarly high levels (Table 1).
The question therefore is, why? Based on extensive sequenc-
ing analyses of the CEs of several di¡erent epithelia, we have
documented that SPR proteins in general function as cross-
bridgers between other proteins within the CE structure [9,10].
Furthermore, we have noted that the sum of SPR+loricrin
contents of CEs of many epithelia is constant at about 80%,
but that the amount of SPRs varies in direct proportion to the
presumed requirements of the epithelium to withstand me-
chanical abrasion and wear-and-tear [9,10]. In this way, we
have proposed that SPRs function to modify the biomechan-
ical properties of the CEs and thus of the entire epithelium.
As examples, CEs of trunk epidermis contain few SPR pro-
teins, those of lip and footpad epidermis contain about 10%
SPRs, and CEs of rodent forestomach contain about 20%
SPRs. In buccal and gingival tissues and derived NHGK cells,
the sum of SPRs+loricrin is also about 65^75% (Table 1).
Therefore, we conclude that buccal and gingival CEs contain
high levels of SPRs speci¢cally for biomechanical purposes;
indeed we are unaware of other epithelial tissues that are
likely to be subjected to more mechanical stresses and insults
from the environment.
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